| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abnormal pretreatment coagulation factor levels correlate with poor prognosis in patients with early-stage extranodal nasal-type natural/killer T cell lymphoma
|
Chai, Yue
|
|
|
99 |
6 |
p. 1303-1309
|
artikel
|
| 2 |
Absence of influence of peripheral blood CD34+ and CD3+ graft cell counts on outcomes after reduced-intensity conditioning transplantation using post-transplant cyclophosphamide
|
Garnier, Alice
|
|
|
99 |
6 |
p. 1341-1350
|
artikel
|
| 3 |
A case of idiopathic multicentric Castleman disease presenting with diffuse lung cysts: how to evaluate treatment response?
|
Ma, Wanlu
|
|
|
99 |
6 |
p. 1401-1402
|
artikel
|
| 4 |
Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia conducted in Japan during the past quarter century
|
Yanada, Masamitsu
|
|
|
99 |
6 |
p. 1351-1360
|
artikel
|
| 5 |
A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the final analysis
|
Yoon, Sang Eun
|
|
|
99 |
6 |
p. 1283-1291
|
artikel
|
| 6 |
Clinical characteristics and outcomes of oligosecretory and non-secretory multiple myeloma
|
Migkou, Magdalini
|
|
|
99 |
6 |
p. 1251-1255
|
artikel
|
| 7 |
Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia
|
Gupta, Charu
|
|
|
99 |
6 |
p. 1415-1417
|
artikel
|
| 8 |
Comparison of ATG-thymoglobulin with ATG-Fresenius for Epstein-Barr virus infections and graft-versus-host-disease in patients with hematological malignances after haploidentical hematopoietic stem cell transplantation: a single-center experience
|
Zhou, Ling
|
|
|
99 |
6 |
p. 1389-1400
|
artikel
|
| 9 |
How to treat myelodysplastic syndrome with clinical features resembling Behçet syndrome: a case-based systematic review
|
Yilmaz, Umut
|
|
|
99 |
6 |
p. 1193-1203
|
artikel
|
| 10 |
Hypomethylating agents super-responders: challenging the dogma of long-term remission for acute myeloid leukemia
|
Maakaron, Joseph E.
|
|
|
99 |
6 |
p. 1411-1413
|
artikel
|
| 11 |
Immunodeficiency risk score for prediction of mortality by parainfluenza virus infection in patients with hematologic malignancy
|
Lee, Jeongsoo
|
|
|
99 |
6 |
p. 1231-1239
|
artikel
|
| 12 |
Impact of blood pressure early after allogeneic hematopoietic cell transplantation on clinical outcomes
|
Tamaki, Masaharu
|
|
|
99 |
6 |
p. 1369-1376
|
artikel
|
| 13 |
Ixazomib-based regimens for relapsed/refractory multiple myeloma: are real-world data compatible with clinical trial outcomes? A multi-site Israeli registry study
|
Cohen, Yael C.
|
|
|
99 |
6 |
p. 1273-1281
|
artikel
|
| 14 |
Long PFS of more than 7 years is achieved in 9% of myeloma patients in the era of conventional chemotherapy and of first-generation novel anti-myeloma agents: a single-center experience over 20-year period
|
Terpos, Evangelos
|
|
|
99 |
6 |
p. 1257-1264
|
artikel
|
| 15 |
Management of myelofibrosis after ruxolitinib failure
|
Harrison, Claire N
|
|
|
99 |
6 |
p. 1177-1191
|
artikel
|
| 16 |
Mechanism of thrombocytopenia in COVID-19 patients
|
Xu, Panyang
|
|
|
99 |
6 |
p. 1205-1208
|
artikel
|
| 17 |
Outcomes related to intravenous fluid administration in sickle cell patients during vaso-occlusive crisis
|
Gaut, Daria
|
|
|
99 |
6 |
p. 1217-1223
|
artikel
|
| 18 |
Pegfilgrastim improves the outcomes of mobilization and engraftment in autologous hematopoietic stem cell transplantation for the treatment of multiple myeloma
|
Ding, Xiao
|
|
|
99 |
6 |
p. 1331-1339
|
artikel
|
| 19 |
Plasma cell-free DNA is a prognostic biomarker for survival in patients with aggressive non-Hodgkin lymphomas
|
Hur, Joon Young
|
|
|
99 |
6 |
p. 1293-1302
|
artikel
|
| 20 |
Post-transplant cyclophosphamide combined with anti-thymocyte globulin for graft-vs-host disease prophylaxis improves survival and lowers non-relapse mortality in older patients undergoing allogeneic hematopoietic cell transplantation
|
Pasic, Ivan
|
|
|
99 |
6 |
p. 1377-1387
|
artikel
|
| 21 |
Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in elderly HL: a two-center experience in 123 patients
|
Albano, Domenico
|
|
|
99 |
6 |
p. 1321-1330
|
artikel
|
| 22 |
Red blood cell consumption in a large cohort of patients with thalassaemia: a retrospective analysis of main predictors
|
Ricchi, Paolo
|
|
|
99 |
6 |
p. 1209-1215
|
artikel
|
| 23 |
Relationship between molecular response and quality of life with bosutinib or imatinib for chronic myeloid leukemia
|
Brümmendorf, Tim H.
|
|
|
99 |
6 |
p. 1241-1249
|
artikel
|
| 24 |
Risk of kidney toxicity with carfilzomib in multiple myeloma: a meta-analysis of randomized controlled trials
|
Ball, Somedeb
|
|
|
99 |
6 |
p. 1265-1271
|
artikel
|
| 25 |
Ruxolitinib-based combinations in the treatment of myelofibrosis: worth looking forward to
|
Li, Yujin
|
|
|
99 |
6 |
p. 1161-1176
|
artikel
|
| 26 |
Sickle cell anemia in the state of Maranhão: a haplotype study
|
Alves, Ademilton Costa
|
|
|
99 |
6 |
p. 1225-1230
|
artikel
|
| 27 |
Signals of Th2 immune response from COVID-19 patients requiring intensive care
|
Roncati, Luca
|
|
|
99 |
6 |
p. 1419-1420
|
artikel
|
| 28 |
Subcutaneous marginal zone lymphoma: an unusual lipoma-like presentation
|
Zanelli, Magda
|
|
|
99 |
6 |
p. 1409-1410
|
artikel
|
| 29 |
The concomitance of lymphoma and breast carcinoma in the bone
|
Autore, Francesco
|
|
|
99 |
6 |
p. 1403-1404
|
artikel
|
| 30 |
The management of gynecological complications in long-term survivors after allogeneic hematopoietic cell transplantation—a single-center real-life experience
|
Klasa, Łukasz
|
|
|
99 |
6 |
p. 1361-1368
|
artikel
|
| 31 |
Treatment strategy in a patient showing borderline features between plasmablastic lymphoma and plasmablastic myeloma harboring a 17p deletion
|
Yoshihara, Kyoko
|
|
|
99 |
6 |
p. 1405-1407
|
artikel
|
| 32 |
Upfront autologous stem cell transplantation for untreated diffuse large B cell lymphoma patients in rituximab era: a systematic review and meta-analysis
|
Ma, Shu-Yun
|
|
|
99 |
6 |
p. 1311-1319
|
artikel
|
Tijdschrift beschrijving